{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:33:19Z","timestamp":1792683199803,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013499","name":"Allergias\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013499","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.canlet.2024.217352","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T12:40:25Z","timestamp":1732365625000},"page":"217352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer"],"prefix":"10.1016","volume":"609","author":[{"given":"Lo\u00efc","family":"Steiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eldh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarijn","family":"Offens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne E.","family":"Veerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammer","family":"Hemdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Netterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2332-0653","authenticated-orcid":false,"given":"Ylva","family":"Huge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Abdul-Sattar Aljabery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhood","family":"Alamdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Lid\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Gabrielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canlet.2024.217352_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canlet.2024.217352_bib2","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1017\/S1462399410001407","article-title":"Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC)","volume":"12","author":"Pollard","year":"2010","journal-title":"Expet Rev. Mol. Med."},{"issue":"17","key":"10.1016\/j.canlet.2024.217352_bib3","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/cncr.28147","article-title":"Recurrence of high-risk bladder cancer: a population-based analysis","volume":"119","author":"Chamie","year":"2013","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2024.217352_bib4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.eururo.2011.12.010","article-title":"Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer","volume":"61","author":"Rosenblatt","year":"2012","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217352_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/21681805.2019.1624611","article-title":"Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival","volume":"53","author":"Russell","year":"2019","journal-title":"Scand J. Urol."},{"issue":"18","key":"10.1016\/j.canlet.2024.217352_bib6","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/cncr.24466","article-title":"Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy","volume":"115","author":"Sonpavde","year":"2009","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.canlet.2024.217352_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-5347(17)37318-4","article-title":"The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group","volume":"147","author":"Splinter","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2024.217352_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221149266","article-title":"The rise of extracellular vesicles as new age biomarkers in cancer diagnosis: promises and pitfalls","volume":"22","author":"Bamankar","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.canlet.2024.217352_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123841","article-title":"UBC((R)) rapid test-A urinary point-of-care (POC) assay for diagnosis of bladder cancer with a focus on non-muscle invasive high-grade tumors: results of a multicenter-study","volume":"19","author":"Ecke","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.canlet.2024.217352_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/intimm\/dxh267","article-title":"Exosomal-like vesicles are present in human blood plasma","volume":"17","author":"Caby","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.canlet.2024.217352_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-9-9","article-title":"Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages","volume":"9","author":"Lasser","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2024.217352_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.canlet.2024.217352_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Thery","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217352_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.canlet.2024.217352_bib15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.canlet.2024.217352_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115170","article-title":"Egr-1 activation by cancer-derived extracellular vesicles promotes endothelial cell migration via ERK1\/2 and JNK signaling pathways","volume":"9","author":"Yoon","year":"2014","journal-title":"PLoS One"},{"issue":"7578","key":"10.1016\/j.canlet.2024.217352_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.canlet.2024.217352_bib18","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1074\/jbc.RA118.006682","article-title":"Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells","volume":"294","author":"Wu","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.canlet.2024.217352_bib19","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/nm1216-1502b","article-title":"Corrigendum: melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"22","author":"Peinado","year":"2016","journal-title":"Nat. Med."},{"issue":"3\u20134","key":"10.1016\/j.canlet.2024.217352_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/prca.201400114","article-title":"Exosomes in bodily fluids are a highly stable resource of disease biomarkers","volume":"9","author":"Boukouris","year":"2015","journal-title":"Proteonomics Clin. Appl."},{"issue":"10","key":"10.1016\/j.canlet.2024.217352_bib21","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/sj.bjc.6605058","article-title":"Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer","volume":"100","author":"Nilsson","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"15","key":"10.1016\/j.canlet.2024.217352_bib22","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.7150\/jca.25201","article-title":"Exosomal ephrinA2 derived from serum as a potential biomarker for prostate cancer","volume":"9","author":"Li","year":"2018","journal-title":"J. Cancer"},{"issue":"18","key":"10.1016\/j.canlet.2024.217352_bib23","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1002\/cam4.4168","article-title":"Exosomal TUBB3 mRNA expression of metastatic castration-resistant prostate cancer patients: association with patient outcome under abiraterone","volume":"10","author":"Zhu","year":"2021","journal-title":"Cancer Med."},{"issue":"11","key":"10.1016\/j.canlet.2024.217352_bib24","doi-asserted-by":"crossref","first-page":"11075","DOI":"10.1021\/acsnano.5b04527","article-title":"Label-free nanoplasmonic-based short noncoding RNA sensing at attomolar concentrations allows for quantitative and highly specific assay of MicroRNA-10b in biological fluids and circulating exosomes","volume":"9","author":"Joshi","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2024.217352_bib25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bios.2019.01.039","article-title":"Dual-SERS biosensor for one-step detection of microRNAs in exosome and residual plasma of blood samples for diagnosing pancreatic cancer","volume":"130","author":"Pang","year":"2019","journal-title":"Biosens. Bioelectron."},{"issue":"4","key":"10.1016\/j.canlet.2024.217352_bib26","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1021\/acsnano.7b08199","article-title":"Integrated analysis of exosomal protein biomarkers on alternating current electrokinetic chips enables rapid detection of pancreatic cancer in patient blood","volume":"12","author":"Lewis","year":"2018","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.canlet.2024.217352_bib27","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","article-title":"Extracellular vesicle and particle biomarkers define multiple human cancers","volume":"182","author":"Hoshino","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.canlet.2024.217352_bib28","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1074\/mcp.M116.064725","article-title":"Tracing cellular origin of human exosomes using multiplex proximity extension assays","volume":"16","author":"Larssen","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"issue":"2","key":"10.1016\/j.canlet.2024.217352_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.canlet.2024.217352_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12253-010-9320-4","article-title":"Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer","volume":"17","author":"Szarvas","year":"2011","journal-title":"Pathol. Oncol. Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.217352_bib31","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1349-7006.2010.01506.x","article-title":"Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer","volume":"101","author":"Szarvas","year":"2010","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.canlet.2024.217352_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12885-023-11100-0","article-title":"Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer","volume":"23","author":"Kerzeli","year":"2023","journal-title":"BMC Cancer"},{"issue":"11\u201312","key":"10.1016\/j.canlet.2024.217352_bib33","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1089\/ars.2005.7.1688","article-title":"Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection","volume":"7","author":"Prawan","year":"2005","journal-title":"Antioxidants Redox Signal."},{"issue":"12","key":"10.1016\/j.canlet.2024.217352_bib34","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1089\/ars.2007.1659","article-title":"Heme oxygenase-1 in tumors: is it a false friend?","volume":"9","author":"Jozkowicz","year":"2007","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.canlet.2024.217352_bib35","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1751-1097.2009.00543.x","article-title":"siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines","volume":"85","author":"Miyake","year":"2009","journal-title":"Photochem. Photobiol."},{"issue":"6","key":"10.1016\/j.canlet.2024.217352_bib36","first-page":"2145","article-title":"Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells","volume":"30","author":"Miyake","year":"2010","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2024.217352_bib37","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1158\/1078-0432.CCR-04-2159","article-title":"Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment","volume":"11","author":"Berberat","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217352_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1025803600840","article-title":"Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer","volume":"6","author":"Sunamura","year":"2003","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.canlet.2024.217352_bib39","first-page":"1107","article-title":"Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas","volume":"5","author":"Nishie","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2024.217352_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"issue":"3","key":"10.1016\/j.canlet.2024.217352_bib41","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-018-4760-8","article-title":"MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis","volume":"170","author":"Dutta","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.canlet.2024.217352_bib42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5213\/inj.2040366.183","article-title":"Potential role of monocyte chemoattractant protein-1 in monitoring disease progression and response to treatment in overactive bladder patients","volume":"24","author":"Ghoniem","year":"2020","journal-title":"Int Neurourol J"},{"issue":"1","key":"10.1016\/j.canlet.2024.217352_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1464-410x.1998.00675.x","article-title":"Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer","volume":"82","author":"Amann","year":"1998","journal-title":"Br. J. Urol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217352_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-021-02215-y","article-title":"The CD70-CD27 axis in oncology: the new kids on the block","volume":"41","author":"Flieswasser","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217352_bib45","article-title":"The biology and function of extracellular vesicles in cancer development","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217352_bib46","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1038\/s41598-020-62753-x","article-title":"Urinary exosomes from bladder cancer patients show a residual cancer phenotype despite complete pathological downstaging","volume":"10","author":"Hiltbrunner","year":"2020","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.canlet.2024.217352_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133242","article-title":"Proteomic profiling of tissue exosomes indicates continuous release of malignant exosomes in urinary bladder cancer patients, even with pathologically undetectable tumour","volume":"13","author":"Eldh","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.canlet.2024.217352_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/biom13060932","article-title":"Protein biomarker discovery studies on urinary sEV fractions separated with UF-SEC for the first diagnosis and detection of recurrence in bladder cancer patients","volume":"13","author":"Jordaens","year":"2023","journal-title":"Biomolecules"},{"issue":"15","key":"10.1016\/j.canlet.2024.217352_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr424","article-title":"Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood","volume":"39","author":"Lundberg","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.217352_bib50","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nbt0502-473","article-title":"Protein detection using proximity-dependent DNA ligation assays","volume":"20","author":"Fredriksson","year":"2002","journal-title":"Nat. Biotechnol."}],"updated-by":[{"DOI":"10.1016\/j.canlet.2025.217876","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000}},{"DOI":"10.1016\/j.canlet.2025.217592","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000}}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400747X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400747X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:05:00Z","timestamp":1757498700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352400747X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":50,"alternative-id":["S030438352400747X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217352","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.canlet.2025.217592","asserted-by":"object"},{"id-type":"doi","id":"10.1016\/j.canlet.2025.217876","asserted-by":"object"}]},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217352"}}